(Q33331230)

English

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Treatment of unresectable, locally advanced pancreatic adenocarcinoma with combined radiochemotherapy with 5-fluorouracil, leucovorin and cisplatin (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

chemoradiotherapy

0 references

1 reference

based on heuristic

inferred from title

pancreatic adenocarcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kornek GV

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Schratter-Sehn A

2

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Marczell A

3

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Depisch D

4

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Karner J

5

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Krauss G

6

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Haider K

7

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Kwasny W

8

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Locker G

9

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Scheithauer W

10

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

82

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

98-103

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Combined modality therapy for stage II and stage III pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Combined modality treatment with accelerated radiotherapy and chemotherapy in patients with locally advanced inoperable carcinoma of the pancreas: results of a feasibility study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Phase II trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Chemotherapy of adenocarcinoma of the pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Cisplatin and protracted venous infusion 5-fluorouracil (CF)--good symptom relief with low toxicity in advanced pancreatic carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Neoadjuvant chemoradiation in pancreatic and duodenal carcinoma. A Phase II Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Early evaluation of combined fluorouracil and leucovorin as a radiation enhancer for locally unresectable, residual, or recurrent gastrointestinal carcinoma. The North Central Cancer Treatment Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Resection margins in carcinoma of the head of the pancreas. Implications for radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Carcinoma of the pancreas: critical analysis of costs, results of resections, and the need for standardized reporting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Concurrent chemotherapy and radiation therapy followed by transhiatal esophagectomy for local-regional cancer of the esophagus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

21 June 2018

Cancer statistics, 1996.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

31 October 2018

Lymphatic and local spread of T1 and T2 pancreatic cancer. A study of autopsy material

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2363209

31 October 2018

Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Leucovorin and 5-fluorouracil as a treatment for disseminated cancer of the pancreas and unknown primary tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative and adjuvant chemotherapy in non-small cell lung cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion high-dose leucovorin with 5-fluorouracil and cisplatin for untreated stage IV carcinoma of the head and neck

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of failure after curative resection of pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Continuous infusion 5-fluorouracil plus weekly cisplatin for pancreatic carcinoma. A Mid-Atlantic Oncology Program study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pancreatic carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801)

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized comparison of fluorouracil and leucovorin therapy versus fluorouracil, leucovorin, and cisplatin therapy in patients with advanced colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II survival comparison of patients with adenocarcinoma of the pancreas treated with 5-fluorouracil and calcium leucovorin versus a matched tumor registry control population

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for advanced pancreatic cancer - some light at the end of the tunnel?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapy of locally unresectable pancreatic carcinoma: a randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/10638974

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1054/BJOC.1999.0884

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33331230&oldid=2195250914"